Filters close
Newswise: Yale Cancer Center Research Shows Former Diabetes Drug May Aid in Breast Cancer Treatment
Released: 10-Dec-2021 12:20 PM EST
Yale Cancer Center Research Shows Former Diabetes Drug May Aid in Breast Cancer Treatment
Yale Cancer Center/Smilow Cancer Hospital

Findings from a new study led by Yale Cancer Center show the small molecule inhibitor drug, PF05175157, originally developed to treat diabetes by Pfizer, may help in the treatment of breast cancer. The findings were reported today at the 2021 San Antonio Breast Cancer Symposium in San Antonio, Texas.

Newswise: Yale Cancer Center Study Offers Clue to Why Some Young Women Develop Breast Cancer
9-Dec-2021 8:00 AM EST
Yale Cancer Center Study Offers Clue to Why Some Young Women Develop Breast Cancer
Yale Cancer Center/Smilow Cancer Hospital

New research led by Yale Cancer Center reveals young women with breast cancer and a family history of the disease, but no high penetrance germline mutations, have an increased number of rare germline variants in cancer-relevant genes.

Newswise: Early Detection Research at Yale Cancer Center Could be a Game Changer for Hard to Diagnose Pancreatic Cancer
Released: 16-Nov-2021 9:45 AM EST
Early Detection Research at Yale Cancer Center Could be a Game Changer for Hard to Diagnose Pancreatic Cancer
Yale Cancer Center/Smilow Cancer Hospital

In recognition of Pancreatic Cancer Awareness Month in November, Yale Cancer Center early detection research is providing new reason for optimism.

Newswise: Yale Cancer Center Experts Co-Author Book on War on Cancer
Released: 16-Nov-2021 9:45 AM EST
Yale Cancer Center Experts Co-Author Book on War on Cancer
Yale Cancer Center/Smilow Cancer Hospital

Several Yale Cancer Center faculty have authored chapters in a newly released book, A New Deal For Cancer: Lessons from a 50 Year War.

Newswise: Yale Cancer Center Study Shows Rates of PSA Testing for Prostate Cancer Increased After Revised National Guidelines
11-Nov-2021 9:00 AM EST
Yale Cancer Center Study Shows Rates of PSA Testing for Prostate Cancer Increased After Revised National Guidelines
Yale Cancer Center/Smilow Cancer Hospital

In a large study led by Yale Cancer Center, more men received a prostate-specific antigen or PSA test to detect prostate cancer following revisions to the recommendation by the U.S. Preventative Services Task Force on screening. The results also showed significant increases in PSA testing among older men, a group for whom screening is not routinely recommended.

Newswise: Yale Cancer Center Study Shows New Strategy to Fight Drug Resistance in HER2-Positive Breast and Ovarian Cancers
26-Oct-2021 11:20 AM EDT
Yale Cancer Center Study Shows New Strategy to Fight Drug Resistance in HER2-Positive Breast and Ovarian Cancers
Yale Cancer Center/Smilow Cancer Hospital

New findings by researchers at Yale Cancer Center demonstrate a novel strategy to treat tumor growth in breast and ovarian cancers characterized by HER2 gene amplification, an increase in the number of copies of a gene.

Released: 20-Oct-2021 11:00 AM EDT
Tissue Mapping Center for Cellular Senescence Launched at Yale Cancer Center to Study Human Lymphoid Organs
Yale Cancer Center/Smilow Cancer Hospital

The National Institutes of Health has awarded a grant to fund cellular senescence research in lymphoid organs at Yale Cancer Center.

19-Oct-2021 4:25 PM EDT
Yale Cancer Center Study Shows New Strategy to Boost Immune System to Fight Melanoma
Yale Cancer Center/Smilow Cancer Hospital

A new study led by Yale Cancer Center researchers shows that the enzyme KDM5B suppresses anti-melanoma immunity.

Newswise: What You Need to Know About the PALB2 Breast Cancer Gene
Released: 12-Oct-2021 12:00 PM EDT
What You Need to Know About the PALB2 Breast Cancer Gene
Yale Cancer Center/Smilow Cancer Hospital

Yale Cancer Center and Smilow Cancer Hospital experts explain why the PALB2 gene can increase your breast cancer risk.

Newswise: Pamela Kunz, MD, Named Woman Oncologist of the Year
Released: 12-Oct-2021 11:50 AM EDT
Pamela Kunz, MD, Named Woman Oncologist of the Year
Yale Cancer Center/Smilow Cancer Hospital

Women Leaders in Oncology (WLO) has named Pamela Kunz, MD, the 2021 Woman Oncologist of the Year. Kunz is Associate Professor of Medicine (Medical Oncology), Director of the Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center, Chief of GI Medical Oncology and Vice Chief, Diversity Equity and Inclusion, Medical Oncology.

Newswise: Yale Cancer Center's Markus Müschen Receives Prestigious NCI Outstanding Investigator Award
Released: 12-Oct-2021 11:45 AM EDT
Yale Cancer Center's Markus Müschen Receives Prestigious NCI Outstanding Investigator Award
Yale Cancer Center/Smilow Cancer Hospital

The National Cancer Institute has recognized Markus Müschen, MD, PhD, with its Outstanding Investigator Award.

Newswise: Yale Cancer Center Study Finds New Drug Combination Shows Clinical Activity for Patients with Prostate Cancer
17-Sep-2021 5:00 PM EDT
Yale Cancer Center Study Finds New Drug Combination Shows Clinical Activity for Patients with Prostate Cancer
Yale Cancer Center/Smilow Cancer Hospital

New findings by researchers at Yale Cancer Center show the drug combination of nivolumab and rucaparib shows clinical activity for patients with chemotherapy-naïve, metastatic castration resistant prostate cancer.

Newswise: Yale Cancer Center Study Shows New Drug Combinations Improve Outcomes for Patients with Advanced Lung Cancer
16-Sep-2021 5:00 PM EDT
Yale Cancer Center Study Shows New Drug Combinations Improve Outcomes for Patients with Advanced Lung Cancer
Yale Cancer Center/Smilow Cancer Hospital

New findings from a large study led by researchers at Yale Cancer Center shows the addition of the drugs oleclumab or monalizumab to durvalumab improved progression-free survival for patients with locally advanced non-small cell lung cancer.

Newswise: Yale Cancer Center Study Shows Stem-Like T Cells Could Aid Immunotherapy in Cancer Treatment
2-Sep-2021 1:00 PM EDT
Yale Cancer Center Study Shows Stem-Like T Cells Could Aid Immunotherapy in Cancer Treatment
Yale Cancer Center/Smilow Cancer Hospital

In a new study by Yale Cancer Center, researchers show stem-like T cells within certain lymph nodes could be natural cancer fighters.

12-Aug-2021 8:05 AM EDT
Yale Cancer Center Perspective Highlights New Advances for NSCLC
Yale Cancer Center/Smilow Cancer Hospital

A new publication by Yale Cancer Center highlights recent breakthrough therapies developed to treat non-small cell lung cancer (NSCLC). The goal of the study is to provide views on how basic science advances will impact clinical research areas to help influence how NSCLC will be managed over the coming decade.

Released: 17-Jun-2021 1:15 PM EDT
Study Shows Immunotherapy Drug Combination Improves Response in HER2-Negative Breast Cancer Including a Subset of Estrogen Receptor Positive Cancers
Yale Cancer Center/Smilow Cancer Hospital

In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset of estrogen receptor positive cancers.

Released: 15-Jun-2021 12:05 PM EDT
Yale Cancer Center Study Reveals New Pathway for Brain Tumor Therapy
Yale Cancer Center/Smilow Cancer Hospital

In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.

Released: 7-Jun-2021 6:40 PM EDT
Yale Cancer Center Study Shows Novel Test Can Detect New and Recurrent Bladder Cancer
Yale Cancer Center/Smilow Cancer Hospital

A study led by researchers at Yale Cancer Center, Stony Brook University and KDx Diagnostics, Inc., examined a revolutionary new urine screening test that utilizes a novel Keratin 17 (K17) cancer biomarker, and revealed the test can detect the presence of new bladder cancer in patients with hematuria, or blood in the urine.

Released: 22-Apr-2021 4:30 PM EDT
Yale Cancer Center Study Shows Cognitive Impairment for Survivors of Many Pediatric Cancers
Yale Cancer Center/Smilow Cancer Hospital

In a new study led by Yale Cancer Center, researchers report many survivors of childhood cancers receive systemic therapies associated with cognitive effects and chronic health conditions that may impact long-term cognitive outcomes with downstream effects on education, employment, and income. The results were published online today in the Journal of Clinical Oncology (JCO).



close
0.14296